Friday Furnace - 05-30-2025

---

📊 Detailed Summaries 📊

Audit Issues 🔍

iCoreConnect Inc. - iCoreConnect Inc. announced that its previously issued financial statements for the quarter ended September 30, 2024, should no longer be relied upon due to incorrect accounting for warrant and embedded derivative features on convertible debt. The Company will restate these financials in its upcoming Form 10-K and disclosed a material weakness in its internal controls related to complex financial instruments and corporate governance deficiencies. This non-compliance raises concerns about the accuracy of prior financial reporting and the effectiveness of the Company’s disclosure controls and procedures.

Acquisitions and Dispositions 🏗️

BioSig Technologies, Inc. (BSGM - $175.0M) - BioSig Technologies, Inc. completed the acquisition as outlined in the Share Purchase Agreement on May 28, 2025. This transaction finalizes the terms previously disclosed in the Current Reports on Form 8-K filed on May 27, 2025, and the related amendment. The completion of this acquisition may impact the Company’s financial position and operational scope going forward.

GlassBridge Enterprises, Inc. - GlassBridge Enterprises, Inc. completed a securitization transaction involving home equity interest option assets originally purchased from Point Digital Finance, Inc. GB HRP, LLC sold assets for approximately $23.4 million, resulting in net cash proceeds of about $18.8 million after expenses and reinvestments. This transaction reflects the Company's ongoing monetization of its asset portfolio under the master titling trust structure.

Kestrel Group Ltd (KG) - Kestrel Group Ltd completed the issuance of common shares to former Maiden shareholders as part of the Combination Agreement, with all shares registered under the Securities Act pursuant to an effective Form S-4 registration statement. The SEC declared the registration statement effective on March 26, 2025, enabling the transactions contemplated by the Combination Agreement to proceed. The detailed terms and amendments of the Combination Agreement are incorporated by reference and included as exhibits to this filing.

Executive Changes 👋

Rocky Mountain Chocolate Factory, Inc. (RMCF - $9.7M) - Ryan McGrath, Senior Vice President of Operations at Rocky Mountain Chocolate Factory, Inc., has resigned effective July 3, 2025. His departure is not related to any disagreement with the Company or its Board of Directors regarding operations, policies, or practices. The Company will need to address the vacancy in its senior operations leadership.

Proto Labs Inc (PRLB - $909.7M) - Proto Labs Inc. has entered into a Consulting Agreement with former CEO Dr. Robert Bodor, effective May 28, 2025, under which he will provide transitional consulting services through November 11, 2025, for a monthly fee of $5,000. The agreement requires Dr. Bodor to sign a general waiver and release of claims, and the Company may terminate the contract for material breach or failure to comply with the waiver terms. Dr. Bodor retains the right to exercise all vested stock options during the agreement term and for three months following termination, but all unvested options will be forfeited upon expiration or termination.

Flux Power Holdings, Inc. (FLUX - $27.8M) - Flux Power Holdings, Inc. announced that its stockholders approved the 2025 Equity Incentive Plan at the Annual Meeting held on May 28, 2025, reserving 1,000,000 shares of common stock for issuance under the plan. The 2025 Plan aims to attract, retain, and incentivize employees, directors, officers, and consultants through various equity-based awards such as stock options and restricted stock units. This approval follows the Board’s prior approval on February 26, 2025, and the full details of the plan are incorporated by reference from the Company’s April 9, 2025 proxy statement.

Suro Capital Corp (SSSS - $155.2M) - Suro Capital Corp has extended the employment terms of Mr. Klein and Ms. Green by three years, now through December 31, 2029, under newly amended agreements effective May 29, 2025. The amendments grant the Board greater discretion over annual bonuses by setting target amounts instead of fixed limits, potentially impacting executive compensation variability. No other material changes were made to the prior employment agreements, maintaining the existing terms aside from the extension and bonus structure adjustments.

Sow Good Inc. (SOWG - $8.1M) - Brendon Fischer, the Interim Chief Financial Officer of Sow Good Inc., has resigned, effective June 6, 2025. He will support the Company during the transition of his responsibilities before his departure. The resignation is not related to any disagreement with the Company’s operations, accounting, or policies.

TELA Bio, Inc. (TELA - $58.5M) - At the 2025 Annual Meeting, TELA Bio’s stockholders approved a Plan Amendment to increase authorized shares under the 2019 Equity Incentive Plan by 3,500,000 and to eliminate the “evergreen” provision. This amendment had prior Board approval and became effective immediately upon stockholder approval. The full details of the Plan Amendment will be disclosed in the Company’s upcoming Form 10-Q for the quarter ending June 30, 2025.

Terawulf Inc. (WULF - $1.5B) - TeraWulf Inc. announced the appointment of William Tanimoto as Chief Accounting Officer, effective June 20, 2025, replacing Kenneth Deane who resigned to pursue other opportunities. Mr. Tanimoto brings over 14 years of experience in public company audits, including senior roles at Deloitte LLP, and has been with TeraWulf as Director of Financial Reporting since August 2023. There are no related party concerns or material interests disclosed in connection with Mr. Tanimoto’s appointment.

Direct Digital Holdings, Inc. (DRCT - $10.3M) - Direct Digital Holdings, Inc. amended and restated employment agreements with CEO Mark Walker, President Keith Smith, and CFO Diana Diaz, maintaining their base salaries and eligibility for bonuses and equity awards. The agreements enhance severance benefits, notably increasing lump sum payments to two times the target bonus if termination occurs within two years following a change in control, with extended non-competition and non-solicitation covenants during this period. These changes also clarify coverage of affiliates, revise the definition of good reason for resignation, and continue to provide directors’ and officers’ liability insurance and indemnification.

First Foundation Inc. (FFWM - $444.1M) - First Foundation Inc. increased the maximum shares available under its Amended and Restated 2024 Equity Incentive Plan by 2,500,000 shares, raising the total to 4,000,000 shares, with expanded rights granted to the Administrator. Ulrich E. Keller, Jr. resigned from First Foundation Advisors, the Company's investment advisory subsidiary, effective May 23, 2025; he had previously stepped down as executive chairman on October 1, 2024. This departure may impact the advisory operations given Mr. Keller’s prior leadership role.

Phillip Street Middle Market Lending Fund LLC - Ross J. Kari has announced his intention to retire from the Board and all committees of Phillip Street Middle Market Lending Fund LLC, effective May 1, 2026. This planned departure provides the Company with significant lead time to identify and appoint a successor. There are no indications of resignation due to any negative circumstances or non-compliance related to this retirement.

Spectral AI, Inc. (MDAI - $37.8M) - Spectral AI, Inc. has appointed Stanley Micek as its permanent Chief Operating Officer, following his tenure as Interim COO since May 2024. Mr. Micek brings extensive experience from leadership roles at MiMedx Group, Inc. and M2Gen Corp., focusing on business development and commercialization in medical technology. His annual base salary is set at $360,000, with eligibility for a Board-determined discretionary bonus.

SharpLink Gaming, Inc. (SBET - $25.0M) - SharpLink Gaming, Inc. has increased its Board size from four to five directors and elected Joseph Lubin as the new director and Chairman, subject to the closing of the Offering. Mr. Lubin is a highly qualified leader with extensive experience in Ethereum, cryptocurrency technology, and financial investments, including founding Consensys and co-founding Ethereum. His appointment signals a strategic focus on blockchain expertise and treasury strategies, potentially impacting the company's direction and investor confidence.

Ribbon Communications Inc. (RBBN - $630.3M) - Ribbon Communications Inc. announced that its stockholders approved the 2025 Incentive Award Plan at the Annual Meeting, allowing the company to grant awards on up to 14,000,000 shares of common stock plus additional shares available from prior plans. The Plan permits grants of restricted stock units, stock options, stock appreciation rights, and other stock- or cash-based awards to employees, officers, non-employee directors, consultants, and advisors. This approval replaces the prior equity compensation plans and is expected to support the company’s ongoing compensatory arrangements and incentive programs.

Hess Midstream LP (HESM - $4.5B) - Effective upon the closing of the Secondary Offering, William J. Brilliant, Scott E. Telesz, and James K. Lee resigned from the board of directors of GP LLC. Their resignations are part of the governance changes previously disclosed on May 28, 2025. None of the departing directors had any disagreements with the Company regarding its operations, policies, or practices at the time of their resignations.

Goldman Sachs Private Middle Market Credit II LLC - Ross J. Kari has announced his intention to retire from the Board and all committees of Goldman Sachs Private Middle Market Credit II LLC, effective May 1, 2026. This planned departure provides the Company with ample time to identify and appoint a suitable replacement. There are no indications of resignation due to negative circumstances or governance issues.

Boxlight Corp (BOXL - $3.9M) - R. Wayne Jackson resigned as a director of Boxlight Corporation effective May 23, 2025, citing personal reasons. The resignation is not related to any disagreement with the Company’s operations, policies, or practices. The Company acknowledged and appreciated Mr. Jackson’s years of service on the board.

INVO Fertility, Inc. (IVF - $3.5M) - Dr. Daniel Teper resigned as President of INVO Fertility, Inc. effective May 28, 2025. The company will need to appoint a new President to maintain leadership continuity. This departure may impact ongoing strategic initiatives until a replacement is named.

Nu Skin Enterprises Inc. (NUS - $374.1M) - Nu Skin Enterprises Inc. announced that its stockholders approved the Amended and Restated 2024 Omnibus Incentive Plan, which increases the share authorization by 790,000 shares. The Plan clarifies that performance cash awards settled solely in cash are not subject to minimum vesting requirements, potentially impacting executive compensation timing. Additionally, the Plan’s termination date is extended to May 29, 2035, allowing for a longer duration of incentive awards under the Plan.

QVC Group, Inc. (QVCGA - $37.4M) - QVC Group, Inc. has executed a new employment agreement with Gregory B. Maffei to continue as Executive Chairman through at least December 31, 2025, with automatic extension to 2026 unless notice of nonrenewal is given. Mr. Maffei’s annual base salary is set at $1 million retroactive to January 1, 2025, with eligibility for a discretionary bonus determined by the Compensation Committee. If terminated without Cause or for Good Reason, Mr. Maffei is entitled to severance equal to his remaining base salary through the Term, contingent on signing a release.

Silver Capital Holdings LLC - Ross J. Kari has announced his intention to retire from the Board of Silver Capital Holdings LLC and all related committees, effective May 1, 2026. This planned departure provides the Company with advance notice to identify and appoint a successor. The Board expressed gratitude for Mr. Kari’s service and anticipates his continued involvement until his retirement date.

JENA ACQUISITION Corp II (JENA.U) - JENA ACQUISITION Corp II appointed W. Dabbs Cavin, Dexter Fowler, and Tim Hsia to its board of directors effective May 28, 2025, with each joining the Audit, Compensation, and Nominating and Corporate Governance Committees, and serving as chairs of these committees respectively. The Company entered into indemnity agreements with all Directors and Executive Officers, requiring it to indemnify and advance expenses for them to the fullest extent permitted by law. These agreements may expose the Company to potential liability related to legal proceedings involving its directors and officers.

Equifax Inc. (EFX - $32.1B) - Equifax Inc. announced the departure of Todd Horvath, Executive Vice President and President of U.S. Information Solutions, effective June 1, 2025, with CEO Mark Begor temporarily leading the business unit. Horvath will receive a $2.9 million severance payment plus a prorated 2025 incentive award, while his unvested equity awards were forfeited but replaced by a $3.2 million cash payment related to his new hire equity award. The Company has initiated a search for his successor, indicating a significant leadership transition in a key business segment.

Autolus Therapeutics plc (AUTL - $417.8M) - Drs. Joseph Anderson and Martin Murphy have resigned from the Board of Directors of Autolus Therapeutics plc by choosing not to stand for re-election at the 2025 Annual General Meeting. Their departure is explicitly stated to be not due to any disagreement with the Company's management or Board. This change will reduce the number of current directors and may impact Board composition going forward.

Bion Environmental Technologies Inc. - Bion Environmental Technologies Inc. announced the resignation of Turk Stovall from its Board of Directors, effective immediately. The Board simultaneously appointed Mr. Stephen Posner, a financial markets professional with 50 years of experience, to the Board. Mr. Posner’s expertise includes capital raising, corporate strategy, and mergers and acquisitions, which is expected to support the Company’s growth initiatives.

Coda Octopus Group, Inc. (CODA - $84.2M) - G. Tyler Runnels resigned from the Board of Directors of Coda Octopus Group, Inc. on May 27, 2025. The resignation was not due to any disagreements with the Company. This departure does not indicate any conflict or governance issues within the Board.

Bone Biologics Corp (BBLG - $2.7M) - Bone Biologics Corp’s stockholders approved a Plan Amendment increasing the shares reserved under the 2015 Equity Incentive Plan by 30,000,000 shares, raising the total reserved shares to 30,629,489. Of these, 30,354,077 shares remain available for issuance, significantly expanding the company’s equity compensation capacity. This amendment may lead to potential dilution for existing shareholders and indicates an increased focus on equity-based incentives.

AlTi Global, Inc. (ALTI - $335.6M) - AlTi Global, Inc. has entered into a new Executive Employment Agreement with Colleen Graham, its Chief Legal, Compliance and Risk Officer, establishing her annual base salary at $425,000 with eligibility for an annual bonus and participation in equity incentive and senior executive benefit plans. The agreement provides substantial severance protections, including continued salary, bonus payments, equity vesting, and health benefits for up to 12 months in the event of termination without cause or resignation for good reason, as well as lump sum payments and health benefits continuation upon death or disability. The agreement includes customary restrictive covenants and requires 180 days’ notice for voluntary resignation, with severance conditioned on execution of a general release of claims.

Goldman Sachs BDC, Inc. (GSBD - $1.3B) - Ross J. Kari has announced his retirement from the Board of Goldman Sachs BDC, Inc., effective May 1, 2026. He will also step down from all Board committees at that time. The Company expressed gratitude for Mr. Kari’s service and anticipates his continued contributions until his departure.

Global Partners LP (GLP - $1.8B) - Global Partners LP announced the appointment of Thomas P. Jalkut to its Board of Directors following the passing of former Chairman Richard Slifka. Eric Slifka has been named the new Chairman, with Mr. Jalkut serving as Vice Chairman. The Partnership has an ongoing related party relationship with Nutter McClennen and Fish LLP, where Mr. Jalkut is a partner, having paid $733,834 for legal services since January 1, 2024.

Goldman Sachs Private Credit Corp. - Ross J. Kari has announced his retirement from the Board and all committees of Goldman Sachs Private Credit Corp., effective May 1, 2026. This planned departure allows the Company and Board to prepare for a board transition well in advance. No immediate changes to governance or leadership are indicated prior to Mr. Kari’s retirement date.

XOMA Royalty Corp (XOMA - $298.2M) - At the Annual Meeting, XOMA Royalty Corp’s stockholders approved an amendment to the 2010 Long Term Incentive and Stock Award Plan, increasing the shares available for issuance by 880,000 shares. The amended Plan now prohibits payment of dividends and dividend equivalents on unvested awards and includes other ministerial changes. This change could impact the company’s equity compensation expense and shareholder dilution going forward.

TriSalus Life Sciences, Inc. (TLSI - $211.5M) - TriSalus Life Sciences, Inc. announced the resignation of CFO James Young, effective May 30, 2025, with a severance payment of six months' salary and continued vesting of his equity until May 31, 2026. The Company has appointed David Patience as the new CFO, starting July 1, 2025, with a base salary of $450,000, a $159,000 sign-on bonus, and eligibility for an annual bonus of up to 50% of his salary. Mr. Patience is also expected to receive stock options equal to 1% of the outstanding common stock and a performance equity grant in early 2026, subject to Board approval.

Volcon, Inc. (VLCN - $2.6M) - Volcon, Inc. appointed John Kim as CEO effective February 3, 2024, granting him a fully vested ten-year option to purchase 1,443,000 shares, representing 10% of the fully diluted common stock, following stockholder approval. Greg Endo continues as CFO under a new employment agreement with a fully vested ten-year option to purchase 577,200 shares, equal to 4% of the fully diluted common stock, also approved by stockholders. Both option grants vest immediately due to the retirement of all convertible promissory notes, with exercise prices set at the common stock closing price on the Annual Meeting date.

Triller Group Inc. (ILLR - $107.6M) - Bobby Sarnevesht has resigned from the board of directors of Triller Group Inc. due to disagreements with the Board. He did not serve on any key committees at the time of his departure. The Company has formally accepted his resignation and will provide him with a copy of this 8-K filing.

Fate Therapeutics Inc. (FATE - $139.9M) - Fate Therapeutics appointed Matthew Abernethy to its Board and Audit Committee, effective May 29, 2025, replacing Timothy P. Coughlin whose term ended concurrently. Abernethy brings over 15 years of biotechnology finance experience, currently serving as CFO of Neurocrine Biosciences, and received an option grant for 110,000 shares vesting over 36 months contingent on continued service. The Company also entered into an indemnification agreement with Abernethy consistent with other directors, and no related party or other material transactions were disclosed.

Neurocrine Biosciences Inc. (NBIX - $12.1B) - Neurocrine Biosciences announced that Sanjay Keswani, M.D. will succeed Eiry W. Roberts, M.D. as Chief Medical Officer effective June 2, 2025, with Dr. Roberts transitioning to a Strategic Advisor role through December 31, 2025. Dr. Roberts’ Amended Employment Agreement maintains her annual base salary of $731,400, eligibility for a 60% target cash incentive bonus, and substantially the same severance benefits under the Executive Severance Plan. Her outstanding equity awards will remain active and continue to vest during her advisory term.

Material Agreements Signed 🖋️

Trump Media & Technology Group Corp. (DJT - $5.1B) - Trump Media & Technology Group Corp. completed a PIPE Financing issuing 55,857,181 shares at $25.72 per share, raising approximately $1.44 billion, alongside a Debt Financing of $1.0 billion in 0.00% convertible senior secured notes due 2028. The Notes include a mandatory repurchase option for holders on November 30, 2026, and require the Company to maintain a Loan-to-Collateral Ratio of no more than 1.0 within 45 days, secured by Bitcoin and cash collateral. Failure to meet certain reporting conditions or trading restrictions will trigger Additional Interest accrual on the Notes, increasing the Company's potential financial obligations.

Rigetti Computing, Inc. (RGTI - $4.1B) - Rigetti Computing, Inc. entered into a material definitive agreement with Jefferies LLC to establish an at-the-market offering program allowing the Company to sell up to $350 million of common stock at its discretion. The Agent will receive a commission of up to 3.0% on gross proceeds and is not obligated to sell any specific amount, while the Company may suspend or terminate the offering at any time. This program is registered under the Company’s 2025 shelf registration statement, enabling flexible capital raising without immediate dilution or debt issuance.

Immunic Inc. (IMUX - $85.3M) - Immunic Inc. entered into a material definitive underwriting agreement to sell pre-funded warrants and accompanying Series A and Series B warrants for a total of 86,666,667 shares of common stock at a combined price of $0.7499 per unit. The warrants have various exercise prices and expiration terms, including provisions for cashless exercise and ownership limits to prevent any holder from exceeding 4.99% (or 9.99% by election) of the outstanding shares post-exercise. This offering will significantly increase the potential dilution of existing shareholders and provide the company with capital upon warrant exercises.

Mangoceuticals Inc. (MGRX - $20.9M) - Mangoceuticals Inc. entered into two Subscription Agreements issuing 70,454 shares and warrants to purchase 35,227 shares for $116,249, with warrants exercisable at $3.00 per share through May 23, 2028, and subject to beneficial ownership limitations and potential acceleration if the stock price reaches $3.00 for five consecutive days. The Company amended and restated a $500,000 Convertible Promissory Note with Indigo Capital LP, bearing 18% interest and maturing on April 15, 2026, or earlier upon acceleration or mandatory prepayment triggered by a Qualified Financing. These transactions provide Mangoceuticals with additional capital but include acceleration rights and ownership limits that could impact future financing and shareholder dilution.

Apollo Debt Solutions BDC - Apollo Debt Solutions BDC completed a $496 million term debt securitization through its consolidated subsidiary ADL CLO 1 LLC, issuing multiple classes of secured notes and subordinated notes due 2037 with floating interest rates tied to SOFR plus spreads ranging from 1.67% to 4.50%. The securitization includes secured loans totaling $174 million and subordinated notes of $86 million, collectively forming the Company's new secured debt structure under a CLO Indenture with U.S. Bank Trust Company as collateral trustee. This transaction represents a significant financing event that affects the Company's asset coverage and capital structure, potentially impacting its leverage and liquidity profile.

Trailblazer Merger Corp I (TBMC - $53.3M) - Trailblazer Merger Corp I entered into an amendment to its promissory note with Trailblazer Sponsor Group, LLC, increasing the maximum borrowing amount by $500,000 to $4,030,000. The maturity date of the note was revised to the earlier of July 30, 2025, or the closing of the Company’s initial business combination. This amendment potentially impacts the Company’s liquidity and financing structure ahead of its business combination.

Alpha Modus Holdings Inc. (AMOD - $18.7M) - Alpha Modus Holdings, Inc. entered into a material definitive agreement to exchange 3,200,000 shares of Series C Preferred Stock held by four family trusts of CEO William Alessi for 26,079,868 shares of Class A common stock. The trusts, which are related parties due to beneficial ownership by Mr. Alessi, agreed to a lock-up on the common stock until June 13, 2026, limiting transferability except to affiliates. This transaction significantly alters the ownership structure by converting preferred shares held by insiders into common stock, potentially impacting control and voting dynamics.

Aaon Inc. (AAON - $8.2B) - AAON, Inc. and its wholly-owned subsidiaries entered into the Fifth Amendment to their Amended Loan Agreement, increasing the revolving credit commitment from $200 million to $500 million. The existing term loan will be paid off as part of this amendment, and the new maturity date is extended to May 27, 2030. This amendment provides the company with significantly enhanced liquidity and financial flexibility through a larger credit facility.

Solid Power, Inc. (SLDP - $297.7M) - Solid Power Operating, Inc. entered into an Amendment to its Assistance Agreement with the U.S. Department of Energy (DOE), effective May 15, 2025, which imposes new oversight and data reporting requirements. The DOE will now submit periodic data requests, and the Company is required to provide timely and complete responses to these requests and any follow-up inquiries. This amendment increases regulatory scrutiny and administrative obligations under the DOE agreement.

Hepion Pharmaceuticals, Inc. - Hepion Pharmaceuticals has sold all patent assets, knowhow, clinical trial data, and drug product related to Rencofilstat to Panetta Partners for a nominal amount, effectively transferring ownership of these key assets. The Company’s stockholders will receive a contingent value right (CVR) entitling them to milestone payments totaling up to $4.5 million based on FDA approval and net sales thresholds of the licensed product. This transaction indicates Hepion is no longer reliant on Rencofilstat for near-term value creation, shifting potential future upside to contingent payments tied to Panetta’s commercialization success.

LyondellBasell Industries N.V. (LYB - $18.6B) - LyondellBasell Industries N.V. entered into a Seventh Amendment to its $900 million structured accounts receivable facility, extending the term to June 26, 2026. The amendment aligns certain terms with the Company’s senior unsecured revolving credit facility but does not materially change other terms. As of May 29, 2025, there were no outstanding trade receivable purchases or letters of credit under this facility.

Carlyle Group Inc. (CG - $16.7B) - The filing under Item 1.01 for Carlyle Group Inc. references the information disclosed in Item 2.03, indicating no standalone material definitive agreement details are provided here. Investors should review Item 2.03 for the substantive content related to this entry. There are no negative or actionable disclosures explicitly stated in this Item 1.01.

Super League Enterprise, Inc. (SLE - $4.7M) - Super League Enterprise, Inc. completed a public offering of 4,166,666 shares of common stock at $0.12 per share, raising approximately $380,000 in net proceeds after underwriting discounts and expenses. The Company’s underwriter, Aegis Capital Corp., exercised its 45-day option to purchase an additional 416,666 shares, which closed on May 30, 2025. The net proceeds will be used for working capital, general corporate purposes, and to repay a portion of the Company’s indebtedness.

Dutch Bros Inc. (BROS - $8.9B) - Dutch Bros Inc. entered into a material definitive agreement to amend and restate its existing $650 million senior secured credit facility, replacing the 2022 Credit Facility with a new 2025 Credit Facility that provides up to $650 million in credit availability, including a $500 million revolving credit facility and a $150 million term loan. The 2025 Credit Facility includes financial covenants limiting leverage and requiring minimum coverage ratios, as well as negative covenants restricting additional debt, liens, mergers, acquisitions, and asset disposals, and is secured by a first priority perfected security interest in substantially all assets. On the effective date, the company drew the full $150 million term loan and $50 million revolving loan, and the previous credit facility was repaid and terminated.

Reviva Pharmaceuticals Holdings Inc. (RVPH - $51.4M) - Reviva Pharmaceuticals Holdings, Inc. entered into a material definitive agreement for an at-the-market offering program allowing the sale of up to $50 million in common stock through B. Riley Securities and Alliance Global Partners as agents. The shares will be sold pursuant to the Company’s effective shelf Registration Statement on Form S-3, with agents receiving a 3% commission on gross sales proceeds and customary indemnification rights. There is no guarantee of shares sold, and the agents are not obligated to sell any specific amount, but will use commercially reasonable efforts consistent with normal trading practices.

Distoken Acquisition Corp (DIST - $38.4M) - Distoken Acquisition Corp entered into an amended definitive business combination agreement with Youlife Group Inc. and related parties, establishing Pubco as the parent company post-transaction. The Subscription Agreements for a private placement of 2,704,949 Class A shares at $10.00 per share, totaling $27 million, were amended to remove the May 31, 2025 termination date and now allow termination if the Business Combination is not completed by June 30, 2025. The SEC declared effective the Registration Statement on Form F-4 related to the transaction, with definitive proxy statements and prospectuses filed and distributed to shareholders, indicating ongoing regulatory compliance and shareholder communication.

Liberty Media Corp (FWONK - $24.1B) - Liberty Media’s subsidiary LNSPV entered into 2025 Forward Contracts obligating delivery of up to 10.5 million Live Nation shares or cash based on share price performance through early 2027, with price collars set between $109.96 and $179.37 per share. These contracts are tied to the upcoming Split-Off of Liberty Media’s Liberty Live Group, where the new entity, SplitCo, will assume LNSPV’s rights and obligations, including the $1.15 billion liquidity option from Dealers to satisfy potential Debenture put or exchange rights. The arrangement provides SplitCo with a significant liquidity source but also creates contingent obligations linked to Live Nation’s stock price and Debenture holder actions, representing a material financial commitment post-Split-Off.

Enova International, Inc. (ENVA - $2.4B) - Enova International, Inc. completed a material securitization transaction issuing $163.9 million in 2025-A Notes backed by $193 million of unsecured consumer installment loans as collateral. The 2025-A Notes carry a fixed 7.29% coupon, mature in 2031, and are not guaranteed by the Company, exposing Enova to potential risk if the Issuer fails to comply with covenants, which could trigger acceleration of maturity or termination of the facility. The notes were sold exclusively to qualified institutional buyers under exemptions and are subject to strict eligibility and compliance criteria, with failure to meet these potentially leading to forced asset sales by the Indenture Trustee.

Lucid Diagnostics Inc. (LUCD - $154.4M) - Lucid Diagnostics Inc. entered into a material definitive Sales Agreement with Maxim Group LLC to sell up to $25 million of common stock through an “at the market offering” under its effective shelf registration. The Company will pay the Agent a 3.0% commission on gross sales and reimburse legal fees up to specified limits, with the Agreement subject to termination by either party with notice. Net proceeds from the Offering are intended for working capital and general corporate purposes, potentially diluting existing shareholders.

Humana Inc. (HUM - $27.4B) - Humana Inc. entered into a $5.0 billion unsecured revolving credit agreement on May 30, 2025, which increases commitments from $2.642 billion under the prior agreement and replaces the expired $2.1 billion 364-day credit facility. The new agreement includes customary covenants such as a maximum debt to capitalization ratio and permits up to $1.0 billion in incremental commitments. As of the agreement date, Humana has no borrowings outstanding and approximately $14.7 million in undrawn letters of credit, leaving about $4.98 billion available.

iQSTEL Inc (IQST - $28.4M) - iQSTEL Inc. entered into a Material Definitive Agreement to acquire a 51% membership interest in Globetopper, LLC for $700,000 plus additional contingent payments based on EBITDA growth through 2027. The acquisition includes up to $1.2 million in investment over 24 months, contingent on meeting quarterly financial targets, with the Seller remaining as CEO for at least two years. The agreement contains mutual indemnification provisions, with the Seller’s liability capped at 10% of the purchase price, and closing is subject to customary conditions by July 10, 2025, after which either party may terminate.

ReShape Lifesciences Inc. (RSLS - $3.5M) - ReShape Lifesciences Inc. entered into a Material Definitive Agreement with Maxim Group LLC to act as exclusive sales agent for an at-the-market offering of up to $9.7 million in common stock. The Company will pay Maxim a 3.0% commission on gross proceeds plus reimbursement of certain legal fees, with no obligation to sell any shares and the ability to suspend or terminate the offering at any time. This agreement enables ReShape to raise capital flexibly but may result in dilution of existing shareholders if fully utilized.

Private Stock Deals 💸

StepStone Group Inc. (STEP - $4.6B) - StepStone Group Inc. disclosed unregistered sales of equity securities as referenced under Item 8.01 of the filing. No further details are provided directly in Item 3.02, indicating reliance on information in another section. This suggests a private placement or similar transaction that did not involve a public registration process.

Abvc Biopharma Inc. (ABVC - $23.4M) - Abvc Biopharma Inc. completed an unregistered sale of 1,030,413 shares of common stock to 22 Non-U.S. Persons under Regulation S, raising approximately $619,625, with all voting rights transferred to the chairman, Eugene Jiang. The Company accepted additional subscriptions totaling $670,000, resulting in the issuance of 957,144 more shares on the same terms. These securities remain unregistered and cannot be sold to U.S. persons or on U.S. exchanges for one year without SEC registration or an exemption.

Australian Oilseeds Holdings Ltd (COOT - $17.2M) - Australian Oilseeds Holdings Ltd disclosed a sale of equity securities under Item 3.02, referencing Item 8.01 for additional details. The filing does not specify the amount or terms of the equity securities sold, limiting immediate actionable insights. Investors should monitor subsequent disclosures for material information related to this transaction.

Audit Firm Swaps 🔄

Luxurban Hotels Inc. - LuxUrban Hotels Inc. dismissed Grassi & Co., CPAs, P.C. as its independent registered public accounting firm effective May 29, 2025, with no disagreements or reportable events during their engagement. Grassi’s audit reports for 2022 and 2023 included an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern. The Company appointed Bush & Associates CPA as the new independent auditor effective May 30, 2025.

Destiny Media Technologies Inc. - Destiny Media Technologies Inc. announced the resignation of Smythe LLP as its independent registered public accounting firm due to a change in Smythe's policies, with no disagreements or reportable events noted during Smythe’s tenure. The Audit Committee has engaged Davidson & Company LLP as the new independent auditor for the fiscal year ending August 31, 2025, following a competitive selection process. There were no prior consultations or disagreements with Davidson regarding accounting principles or audit opinions for the recent fiscal years or interim period.

Northann Corp. (NCL - $47.2M) - Northann Corp. dismissed its independent registered public accounting firm WWC on May 24, 2025, with no disagreements or reportable events disclosed during the two most recent fiscal years or interim period. WWC’s audit reports for the prior two years were unqualified and contained no adverse opinions or disclaimers. The Company engaged LAO Professionals as its new auditor on May 29, 2025, with no prior consultations or disagreements reported with LAO.

Smartfinancial Inc. (SMBK - $542.0M) - SmartFinancial, Inc. has dismissed Forvis Mazars, LLP as its independent registered public accounting firm effective May 29, 2025, with no prior disagreements or reportable events related to their audit opinions for fiscal years 2023 and 2024. The Audit Committee approved the engagement of Elliott Davis, PLLC as the new independent auditor for the fiscal year ending December 31, 2025, pending standard acceptance procedures. There were no consultations or disagreements with Elliott Davis during the prior two years or interim period that would impact the Company’s financial reporting or audit opinions.

Random Updates 🧩

ProCap Acquisition Corp (PCAPU) - ProCap Acquisition Corp completed its IPO on May 22, 2025, issuing 25,000,000 units at $10.00 each, including 3,000,000 units from the underwriters’ over-allotment option, raising gross proceeds of $250,000,000. Concurrently, the Company sold 430,000 units in a Private Placement to its sponsor for $4,300,000, bringing total proceeds to $254,300,000, which were placed in a U.S.-based trust account. An audited balance sheet as of the IPO closing date, reflecting these proceeds, has been filed as Exhibit 99.1.

Shutterstock, Inc. (SSTK - $646.6M) - Shutterstock, Inc. announced a complex merger transaction with Getty Images involving multiple subsidiary mergers and a conversion of Shutterstock into an LLC, with shareholder approval sought at a special meeting on June 10, 2025. Since filing the Proxy Statement, Shutterstock and its board face litigation through two stockholder lawsuits alleging the Proxy Statement contains false and misleading information and asserting claims of negligent misrepresentation and concealment. These lawsuits pose potential legal and reputational risks that could impact the completion or terms of the merger.

ServiceNow, Inc. (NOW - $212.7B) - ServiceNow, Inc. filed a prospectus supplement on May 30, 2025, to its effective registration statement on Form S-3ASR, enabling certain stockholders to resell shares of the Company’s common stock. These shares were originally acquired through the Company’s acquisition of Logik.io Inc. The filing includes a legal opinion from Freshfields US LLP confirming the validity of the shares.

Catheter Precision, Inc. (VTAK - $2.1M) - Catheter Precision, Inc. reported a net tangible book value deficit of $(15.8) million as of March 31, 2025, translating to $(1.71) per share, which improves only slightly to $(0.95) per share after accounting for recent stock issuances and estimated proceeds from a current at-the-market offering. Existing shareholders experience a modest increase in net tangible book value per share by $0.49, while new investors face a substantial dilution of $(1.25) per share at the assumed offering price of $0.30. This dilution highlights the significant risk to new investors due to the company's ongoing negative equity position and reliance on equity financing.

Summit Therapeutics Inc. (SMMT - $19.0B) - Summit Therapeutics Inc. announced topline results from the Phase III HARMONi trial evaluating ivonescimab combined with chemotherapy, showing a statistically significant and clinically meaningful improvement in progression-free survival. Although the combination demonstrated a positive trend in overall survival, it did not achieve a statistically significant benefit in the primary analysis. These results support the potential clinical value of ivonescimab but may require further data or regulatory discussion due to the lack of definitive overall survival benefit.

Applied Digital Corp. (APLD - $1.7B) - Applied Digital Corporation has classified its Cloud Services Business as held for sale following Board approval and will report it as discontinued operations starting in the fourth quarter of fiscal 2025, reflecting a strategic shift. The Company filed unaudited pro forma financial statements to show the impact of the potential sale as if it occurred at the start of fiscal 2023, though these are preliminary and subject to material adjustments. The sale is not finalized, and actual financial results may differ significantly from the pro forma information provided.

American Integrity Insurance Group, Inc. (AII - $322.9M) - American Integrity Insurance Group, Inc. has fully placed its 2025-2026 indemnity-based catastrophe excess-of-loss reinsurance program, increasing third-party coverage by 45% to $2.59 billion and raising net premiums ceded by 28% to $433 million. The program includes $565 million in multi-year indemnity coverage through new catastrophe bonds, marking the largest ILS transaction sponsored by the Company. The Company’s net retention rises to $35 million for the first two events, reflecting growth in written premium, exposure, and capital, with all reinsurers rated A- or better or posting full collateral.

WinVest Acquisition Corp. - WinVest Acquisition Corp. adjourned its special meeting of stockholders without conducting any business to allow further solicitation of proxies, rescheduling the meeting to June 27, 2025. The deadline for holders of common stock to submit or withdraw redemption requests related to the proposed Business Combination has been extended to June 25, 2025. Stockholders are encouraged to review the Proxy Statement/Prospectus filed with the SEC and vote on the proposals related to the Business Combination involving WinVest BVI, Xtribe PLC, and Xtribe BVI.

Idacorp Inc. (IDA - $6.4B) - Idaho Power filed a general rate case requesting approximately $199.1 million in additional annual revenues, which would result in a 13.09 percent average net base rate increase for Idaho customers if approved. The filing seeks approval for a 10.4 percent return on equity, a revised power cost adjustment, updated rate recovery for certain plants, and authorization for new tracking mechanisms related to depreciation, wildfire mitigation, and tax credit amortization. The company cannot predict the outcome of the case, but new rates are expected to become effective on or after January 1, 2026, pending regulatory approval.

Eversource Energy (ES - $23.7B) - Eversource Energy entered into an Equity Distribution Agreement allowing the company to issue and sell up to $1.2 billion of common shares through a syndicate of major investment banks. This offering is made under an effective Form S-3ASR registration statement and includes a filed prospectus supplement dated May 30, 2025. There are no indications of litigation, impairment, or other negative events associated with this equity offering.

Greenlane Holdings, Inc. (GNLN - $5.9M) - Greenlane Holdings, Inc. reported an aggregate of 1,039,735,642 shares of common stock outstanding as of May 29, 2025. The Company relocated its principal executive offices within Boca Raton, Florida, moving to 4800 North Federal Highway, Suite B200. There are no indications of negative events such as non-compliance or litigation in this filing.

News Corp (NWS - $18.4B) - News Corp continues its authorized stock repurchase program to acquire up to $1 billion of Class A and Class B common stock. The Company complies with Australian Securities Exchange rules by providing daily disclosure of repurchase transactions and includes this information in its quarterly and annual reports. The filing contains forward-looking statements subject to market risks and uncertainties, with no obligation to update these statements except as required by law.

Oak Woods Acquisition Corp (OAKU) - Oak Woods Acquisition Corp has extended the deadline to complete its initial business combination to June 28, 2025, marking the third of six permitted one-month extensions. The extension is contingent upon the Sponsor’s timely deposit of $172,500 into the Trust Account, which has been made as of May 30, 2025. Failure to complete the business combination by the final extension could result in liquidation or other adverse consequences for shareholders.

HCW Biologics Inc. (HCWB - $15.4M) - HCW Biologics Inc. issued a total of 374,140 shares of common stock to Armistice Capital Master Fund Ltd. through the exercise of pre-funded warrants between May 15 and May 29, 2025. Armistice has exercised additional warrants as of May 28, 2025, resulting in the issuance of 71,000 more shares on May 29, 2025. Following these transactions, Armistice still holds pre-funded warrants to purchase up to 139,000 shares of common stock.

Triumph Financial, Inc. (TFIN - $1.4B) - Triumph Financial, Inc. declared a quarterly cash dividend of $17.81 per share on its 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock, payable June 30, 2025, to shareholders of record on June 15, 2025. The filing includes extensive forward-looking statements highlighting numerous risks and uncertainties that could materially affect future results, including credit risk, asset quality deterioration, and potential impairment of investment securities. Investors should be cautious as these risks may impact the company's ability to maintain earnings trends and successfully integrate acquisitions.

Bannix Acquisition Corp. - VisionWave Holdings Inc., a subsidiary of Bannix Acquisition Corp., entered into deferment agreements deferring approximately $3.0 million in obligations to affiliated entities and a former service provider to support liquidity for a potential financing transaction. The deferred amounts, including $2.0 million owed to insiders, will not be payable until prepaid advances related to the financing are fully repaid, with no guarantee the financing will be completed. This coordinated deferment aims to prioritize VisionWave’s launch and capital development, but VisionWave retains discretion over future payment timing and methods.

Aetherium Acquisition Corp - Aetherium Acquisition Corp announced the postponement of its Special Meeting from May 30, 2025, to June 13, 2025, and extended the redemption right deadline to June 11, 2025. The Company filed a definitive proxy statement with the SEC on May 23, 2025, and no other changes have been made to the Proxy Statement or proxy card as originally filed. Shareholders who have already voted or submitted redemption requests may change or revoke their prior actions before the new deadlines, with detailed instructions provided in the Proxy Statement.

D-Wave Quantum Inc. (QBTS - $5.1B) - D-Wave Quantum Inc. received approximately $80.5 million from the exercise of about 7.0 million warrants at an exercise price of $11.50 each. These warrants were originally assumed during the August 5, 2022 merger with DPCM Capital, Inc. The proceeds provide a significant capital infusion to the Company, potentially strengthening its financial position.

HPS Corporate Lending Fund - HPS Corporate Lending Fund priced a private placement offering of $900 million aggregate principal amount of notes, consisting of $400 million 5.300% notes due 2027 and $500 million 5.850% notes due 2030, targeting qualified institutional buyers and certain non-U.S. persons. The Fund intends to use the net proceeds to reduce borrowings, repay indebtedness, and support general corporate purposes in line with its investment strategy. The offering is expected to close on June 5, 2025, subject to customary conditions, and the notes are not registered under the Securities Act, limiting resale options.

Umb Financial Corp (UMBF - $8.0B) - UMB Financial Corporation priced an underwritten public offering of 12,000,000 depositary shares representing Series B Preferred Stock with a 7.750% fixed-rate reset and a liquidation preference of $10,000 per preferred share. The offering is expected to close on June 12, 2025, with RBC Capital Markets and J.P. Morgan Securities acting as underwriters. This capital raise will increase the Company’s preferred equity, potentially impacting its capital structure and dividend obligations.

Zymeworks Inc. (ZYME - $781.8M) - Zymeworks Inc. announced that its subsidiary, Zymeworks BC Inc., received conditional approval from the NMPA for zanidatamab to treat previously treated, unresectable or metastatic HER2-positive BTC in certain Asian markets, excluding Japan. The approval triggers a $20 million milestone payment to Zymeworks, with potential for up to $144 million in additional development and commercial milestones, plus tiered royalties up to 20% of net sales in BeOne Medicines’ territories. Continued market authorization depends on the verification of clinical benefit through ongoing confirmatory trials, representing a key regulatory risk.

ALT5 Sigma Corp (ALTS - $156.4M) - ALT5 Sigma Corporation announced June 2, 2025, as the record date for the formal separation of its healthcare assets, Alyea Therapeutics Corporation, with the specific method of disposition to be announced later. The company disclosed key leadership appointments for Alyea, including Dr. Amol Soin as prospective CEO and Director, and Dr. Anthony Giordano as prospective Chief Scientific Officer, both bringing extensive expertise in pain management and biotechnology. These strategic leadership changes aim to advance Alyea’s mission to innovate in non-opioid chronic pain solutions, signaling a focused and potentially transformative shift in the company’s healthcare asset strategy.

Bancorp, Inc. (TBBK - $2.4B) - The purchaser failed to consummate the closing or secure an extension by the May 30, 2025 deadline under the amended agreement of sale for the apartment complex collateralizing a $42.9 million loan balance. If the agreement terminates, the Company will retain all earnest money deposits totaling $3.0 million and any additional property investments made by the purchaser through termination. This failure to close introduces uncertainty around the disposition timing and potential recovery of the real estate bridge lending asset.

Perspective Therapeutics, Inc. (CATX - $178.1M) - Perspective Therapeutics, Inc. announced interim results from its Phase 1/2a clinical trial of [212Pb]VMT-α-NET targeting unresectable or metastatic neuroendocrine tumors. These results were presented at the 2025 American Society of Clinical Oncology Annual Meeting, indicating ongoing clinical progress. The press release and presentation are filed as Exhibits 99.1 and 99.2, respectively, providing detailed data for investor review.

Black Spade Acquisition II Co (BSII - $187.4M) - Black Spade Acquisition II Co disclosed that holders of 13,120,874 Class A ordinary shares exercised their right to redeem shares for approximately $135.2 million in cash, leaving about $22.5 million remaining in the trust account. This significant redemption could impact the company's ability to complete the proposed Business Combination with The Generation Essentials Group (TGE). The filing also highlights various risks and uncertainties, including potential termination of agreements, litigation, and failure to obtain shareholder or regulatory approvals that could materially affect the transaction's completion.

Oyster Enterprises II Acquisition Corp (OYSEU) - Oyster Enterprises II Acquisition Corp completed its IPO on May 23, 2025, issuing 25,300,000 units at $10.00 each, including 3,300,000 units from the full exercise of the underwriters’ over-allotment option, raising gross proceeds of $253 million. Concurrently, the Company completed a Private Placement of 708,000 units to related parties, including its sponsor Oyster Enterprises II LLC and BTIG, LLC, generating an additional $7.08 million. All proceeds totaling $260.08 million were placed in a U.S.-based trust account, and an audited balance sheet reflecting these transactions has been filed as Exhibit 99.1.

Portland General Electric Co Or (POR - $4.7B) - Portland General Electric Company (PGE) filed with the Oregon Public Utility Commission to recover an annualized revenue requirement increase of $47 million related to its 200 MW Seaside Battery Energy Storage System, expected to be operational before August 21, 2025. The request includes a rate base increase of $257 million, net of $117 million in Investment Tax Credit benefits, and is based on a 9.34% return on equity approved in a prior rate case. PGE seeks authorization to include this recovery in customer prices by October 31, 2025, but the regulatory outcome remains uncertain as the review process continues.

Unisys Corp (UIS - $349.7M) - Unisys Corp has filed a Form 8-K to present recasted segment financial information reflecting a change in its organizational structure effective January 1, 2025, which integrates business processing solutions into its Enterprise Computing Solutions and Cloud, Applications & Infrastructure Solutions segments. This filing is not an amendment or restatement of the 2024 Form 10-K but updates segment disclosures to align with the new reporting structure. The independent auditor reports remain unchanged except for updated report dates to reflect the segment changes, and no new risks or events are disclosed in this filing.

Upexi Inc. (UPXI - $376.5M) - Upexi Inc. has engaged GMI Digital as its new crypto-native marketing and design service provider, signaling a strategic focus on digital and crypto markets. The company will present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 24-25, 2025, potentially increasing investor visibility. No negative events such as non-compliance or litigation were disclosed in this filing.

MainStreet Bancshares, Inc. (MNSB - $149.3M) - MainStreet Bancshares, Inc. disclosed a data security incident involving a third-party vendor whose compromised system included personally identifiable information of approximately 4.65% of its customers. The Company confirmed that its own systems were not compromised, no unauthorized transactions occurred, and it has ceased all activity with the affected vendor while notifying regulators and impacted customers. The incident is not expected to have a material impact on the Company’s operations, financial condition, or reputation.

KOHLS Corp (KSS - $880.6M) - Kohl’s Corporation completed a $360 million private offering of 10.000% senior secured notes due 2030, with proceeds used to repay borrowings under its revolving credit facility. The Notes are secured by first-priority liens on 11 distribution centers and guaranteed by the Company’s subsidiaries, with covenants restricting additional liens, indebtedness, and asset sales. The Indenture includes events of default that could accelerate repayment and requires repurchase offers upon certain change of control events, increasing potential financial risk.

Columbus Mckinnon Corp (CMCO - $509.1M) - Columbus McKinnon Corp is acquiring Kito Crosby Limited, but the transaction is currently delayed due to a Second Request for additional information from the U.S. Department of Justice’s Antitrust Division, extending the HSR Act waiting period. The parties are actively cooperating with the Antitrust Division to resolve the review as quickly as possible. Completion of the acquisition remains contingent on satisfying or waiving the regulatory waiting period and other customary closing conditions.

Titan Acquisition Corp. (TACHU) - Titan Acquisition Corp. announced that starting on or about June 2, 2025, holders of its Units can elect to separately trade the Class A ordinary shares and warrants included in the Units. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable at $11.50 per share. The Units will continue trading under the symbol "TACHU," while the separated shares and warrants are expected to trade under "TACH" and "TACHW," respectively.

Soundhound Ai Inc. (SOUN - $4.5B) - Soundhound AI Inc. filed a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation on May 29, 2025, with the Delaware Secretary of State. This filing implements the Charter Amendment Proposals previously approved by the company. The Restated Certificate of Incorporation reflecting these changes has been filed as Exhibit 3.1 to the current 8-K.

Earnings Drops 🧮

Loop Industries, Inc. (LOOP - $53.3M) - Loop Industries, Inc. announced its financial results for the fourth quarter and fiscal year ended February 28, 2025, via a press release attached as Exhibit 99.1. The filing clarifies that this information is not deemed filed under the Securities Exchange Act and is not incorporated by reference in other filings. No negative events such as impairment, litigation, or non-compliance were disclosed in this item.

Plus Therapeutics Inc. (PSTV - $4.9M) - Plus Therapeutics, Inc. reported its financial results for the first quarter ended March 31, 2025, as detailed in the press release furnished as Exhibit 99.1. The filing clarifies that this information is furnished and not filed, meaning it is not subject to certain liabilities under the Securities Exchange Act or Securities Act. There are no indications of negative events such as impairment, litigation, or non-compliance in this update.

Charter Tweaks ✏️

Clearside Biomedical, Inc. (CLSD - $63.7M) - Clearside Biomedical, Inc. received stockholder approval to amend its Certificate of Incorporation to increase the authorized shares of common stock from 200 million to 400 million. This amendment was officially filed with the Delaware Secretary of State on May 30, 2025. The increase in authorized shares may enable the Company to pursue additional financing or strategic transactions.

Coherus Oncology, Inc. (CHRS - $90.3M) - Coherus BioSciences, Inc. has officially changed its corporate name to Coherus Oncology, Inc., effective May 29, 2025, as reflected in the filed Certificate of Amendment. This name change does not affect stockholder rights, nor does it require stockholder approval, and the company’s common stock will continue trading on Nasdaq under the symbol “CHRS” with the same CUSIP number. Additionally, the Board approved and implemented amended bylaws to reflect the new corporate name, effective the same date.

Mattel Inc. De (MAT - $6.3B) - At the 2025 Annual Meeting, Mattel’s stockholders approved an amendment to the Restated Certificate of Incorporation extending exculpation from liability to certain officers to the fullest extent permitted by Delaware law. The Company filed the Certificate of Amendment with the Delaware Secretary of State on May 29, 2025, and it became effective immediately. This amendment potentially limits the personal liability of specified officers, which may impact shareholder recourse in future legal matters.

Chevron Corp (CVX - $238.7B) - Chevron Corporation’s stockholders approved amendments to the Restated Certificate of Incorporation that eliminate monetary liability for certain officers under specific circumstances, expanding protections beyond those currently afforded to Directors. These officer exculpation provisions became effective on May 28, 2025, upon filing with the Delaware Secretary of State. This change potentially reduces legal risk exposure for Chevron’s officers in the performance of their duties.

Penumbra Inc (PEN - $10.6B) - Penumbra Inc filed an Amended and Restated Certificate of Incorporation and Third Amended and Restated Bylaws effective May 28, 2025, which phase in the declassification of its Board over three years, transitioning to annual director elections by 2028. The amendments also eliminate the Supermajority Voting Requirement, replacing it with a simple majority vote for certain stockholder actions, reducing the threshold from 66 2/3% to a majority of voting power. These governance changes increase stockholder voting influence and may impact board composition and corporate control dynamics going forward.

Reg FD Buzz 🗞️

Wetouch Technology Inc. (WETH - $11.7M) - Wetouch Technology Inc. disclosed that it has received a Notice from Nasdaq under Listing Rule 5810(b), indicating potential non-compliance with Nasdaq listing standards. The Company is currently working toward regaining compliance, including the expected filing of its Form 10-K and Form 10-Q, but there is no assurance it will meet Nasdaq requirements within the compliance period. This filing contains forward-looking statements highlighting significant risks and uncertainties that could cause actual results to differ materially and adversely from expectations.

Blackstone Real Estate Income Trust, Inc. - Blackstone Real Estate Income Trust, Inc. declared May 2025 distributions for its common stock classes, with gross amounts of $0.0551 per share across all classes. Net distributions vary due to differing stockholder servicing fees, ranging from $0.0451 to $0.0551 per share, payable on or about June 20, 2025. Class C shares have no distribution declared, as they are an accumulating class with income accruing to NAV instead.

Principal Credit Real Estate Income Trust - Principal Credit Real Estate Income Trust declared a distribution of $0.1350 per share for all classes of its common shares for May 2025. The net distribution is payable to shareholders of record on May 30, 2025, with payment expected on or about June 20, 2025. Shareholders may receive the distribution in cash or through the Company’s distribution reinvestment plan.

Conifer Holdings, Inc. (CNFR - $9.9M) - Conifer Holdings, Inc. received a $10.0 million contingent consideration payment on May 30, 2025, under the Interest Purchase Agreement dated August 30, 2024. This payment relates to the sale of the Company's membership interests in Conifer Insurance Services. There are no indications of litigation, non-compliance, or other negative issues associated with this transaction.

Prokidney Corp (PROK - $94.6M) - ProKidney Corp expects to complete the Domestication process by the end of the third quarter of 2025. The filing contains forward-looking statements subject to significant risks and uncertainties that could cause actual results to differ materially from expectations. Investors are cautioned to not place undue reliance on these statements, as the company disclaims any duty to update them except as required by law.

JVSPAC Acquisition Corp. (JVSA - $83.0M) - JVSPAC Acquisition Corp. disclosed a Forbes article referencing the proposed merger transactions with Hotel101 Global and DoubleDragon under the Merger Agreement dated April 8, 2024. The filing emphasizes that this communication is not an offer or solicitation for securities or proxy votes and that any securities offering will comply with applicable securities laws. Shareholders will be asked to vote on the Transactions after the Registration Statement is declared effective and the definitive proxy statement is mailed.

TechTarget, Inc. (TTGT - $511.9M) - TechTarget, Inc. disclosed that it has received a Notice under Nasdaq Listing Rule 5810(b), indicating potential non-compliance with Nasdaq listing requirements. The Company is preparing a compliance plan and filing a Form 10-Q, but there is uncertainty regarding the timing and acceptance of these actions by Nasdaq. There is a risk of additional delays in SEC filings, and the Company cautions that actual results may differ materially from its forward-looking statements.

Apple Hospitality REIT, Inc. (APLE - $2.8B) - Apple Hospitality REIT, Inc. released an updated investor presentation on May 30, 2025, which includes operating statistics for April and May 2025. This presentation is available on the company’s website and is furnished as Exhibit 99.1 to the Form 8-K. The information is disclosed under Regulation FD and is not deemed filed or incorporated by reference for liability purposes under the Securities Exchange Act.

Sila Realty Trust, Inc. (SILA - $1.4B) - Sila Realty Trust, Inc. has made an investor presentation publicly available as of May 30, 2025, for use at upcoming conferences and meetings. This presentation is accessible on the company's investor relations website but is explicitly not filed under the Securities Exchange Act and is not subject to liability under Section 18. The company clarifies that the information is not necessarily material or required by Regulation FD and does not commit to updating it going forward.

Quanex Building Products CORP (NX - $858.2M) - Quanex Building Products CORP declared a quarterly cash dividend of $0.08 per share, payable on June 30, 2025, to shareholders of record as of June 16, 2025. This dividend announcement reflects the Board’s continued commitment to returning capital to shareholders. There are no indications of negative events or changes impacting the company’s financial condition in this disclosure.

Apollo Realty Income Solutions, Inc. - Apollo Realty Income Solutions, Inc. declared May 2025 distributions for all classes of common stock, with net amounts varying by class after deducting management and stockholder servicing fees. The net distributions range from $0.0749 to $0.1121 per share and will be paid in cash or reinvested under the Company's distribution reinvestment plan. Payments are scheduled for on or about June 20, 2025, to stockholders of record as of May 31, 2025.

Financial Attachments 📎

American Resources Corp (AREC - $57.9M) - American Resources Corp (AREC) received a Notification Letter from Nasdaq dated May 29, 2025, indicating potential non-compliance with Nasdaq listing requirements. This letter may signal a risk of delisting if the company does not promptly address the issues identified by Nasdaq. Investors should monitor subsequent filings for updates on the company's efforts to regain compliance and avoid adverse impacts on the stock.

Liberty Latin America Ltd. (LILA - $1.0B) - Liberty Latin America Ltd. filed an Item 9.01 report providing XBRL Inline Taxonomy Extension documents as exhibits, including schema, definition, label, and presentation linkbase files. These exhibits support the company's interactive data filing requirements and enhance the accessibility of its financial statements. There are no indications of non-compliance, litigation, or other negative issues disclosed in this filing.

Rush Street Interactive, Inc. (RSI - $1.1B) - The Item 9.01 filing for Rush Street Interactive, Inc. includes only the submission of an Interactive Data File as Exhibit 104. There are no disclosures of financial restatements, impairments, or material events in this filing. This filing does not indicate any negative developments or changes affecting the company’s financial condition or operations.

Silgan Holdings Inc. (SLGN - $6.0B) - The filing under Item 9.01 for Silgan Holdings Inc. contains only the Cover Page Interactive File embedded with Inline XBRL tags. There are no disclosures of financial statement changes, non-compliance, or other material events in this filing. This submission is purely technical and does not indicate any operational or legal developments.

Docusign Inc. (DOCU - $17.5B) - The Item 9.01 filing for Docusign Inc. contains only the Cover Page Interactive Data File as an exhibit and does not disclose any material events or financial statement updates. There are no indications of non-compliance, impairment, or other adverse developments in this filing. This submission appears to be a routine filing without actionable information for investors.

Meta Platforms, Inc. (META - $1615.0B) - Meta Platforms, Inc. filed an Item 9.01 disclosure providing the Cover Page Interactive Data File with embedded XBRL tags. This exhibit enhances transparency and accessibility of the company's financial data for investors and regulators. There are no indications of non-compliance, litigation, or other adverse issues in this filing.

Cumulus Media Inc. - The filing under Item 9.01 for Cumulus Media Inc. contains only the Cover Page Interactive Data File embedded within the Inline XBRL document. There are no disclosures of financial statement changes, restatements, or material events in this filing. This submission appears to be a routine technical filing with no actionable financial or operational impact.

Brag House Holdings, Inc. (TBH - $6.6M) - Brag House Holdings, Inc. filed an Item 9.01 disclosure including a press release dated May 30, 2025 and an interactive data file. There are no indications of non-compliance, litigation, impairment, or other negative events in this filing. The submission appears to be a routine update without material adverse developments.

NeueHealth, Inc. (NEUE - $60.8M) - The Item 9.01 filing for NeueHealth, Inc. contains only the cover page of the Current Report on Form 8-K formatted in Inline XBRL. There are no financial statements, exhibits, or disclosures of material events included in this filing. Therefore, no actionable information or significant developments are reported in this submission.

Greenwave Technology Solutions, Inc. (GWAV - $12.1M) - The Item 9.01 filing for Greenwave Technology Solutions, Inc. contains only an exhibit related to the cover page interactive data file. There are no disclosures of non-compliance, litigation, or other material events in this filing. No financial statements or significant updates were provided that would impact the company’s current status.

Duos Technologies Group Inc. (DUOT - $96.4M) - Duos Technologies Group Inc. filed an Item 9.01 disclosure providing financial statements and exhibits. The filing includes Exhibit 104, which is the Cover Page Interactive Data File formatted as Inline XBRL. There are no indications of non-compliance, litigation, or other negative events in this filing.

Energy Vault Holdings, Inc. (NRGV - $140.4M) - Energy Vault Holdings, Inc. filed an Item 9.01 report that includes only the cover page formatted in Inline XBRL. There are no financial statements, amendments, or disclosures of non-compliance, litigation, or other material events in this filing. This filing does not provide any new actionable information for investors or portfolio managers.

ContextLogic Inc. (LOGC - $217.7M) - ContextLogic Inc. filed an 8-K including a press release dated May 30, 2025, as Exhibit 99.1. No financial statements or disclosures of non-compliance, impairment, or other adverse events were included in this filing. The filing primarily serves to provide updated corporate information without indicating any negative developments.

Acadia Healthcare Company, Inc. (ACHC - $2.2B) - Acadia Healthcare Company, Inc. filed amendments to its Amended and Restated Incentive Compensation Plan as exhibits 10.1 and 10.2 in this Form 8-K. These amendments were previously disclosed in the Definitive Proxy Statement filed on April 10, 2025. There are no indications of non-compliance, litigation, or other negative events associated with these filings.

Healthstream Inc. (HSTM - $851.7M) - The Item 9.01 filing for Healthstream Inc. contains only the Cover Page Interactive Data File with embedded XBRL tags. There are no disclosures of financial statement changes, non-compliance, or other material events in this filing. No negative developments or actionable items are reported in this submission.

Shareholder Votes 🗳️

Tenaya Therapeutics, Inc. (TNYA - $73.8M) - At the May 28, 2025 annual meeting, Tenaya Therapeutics’ stockholders elected all Class I director nominees to serve until 2028, despite significant withheld votes for two nominees. The stockholders also ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2025 with overwhelming support. There were no indications of non-compliance or contested matters in the voting results.

Metropolitan Bank Holding Corp. (MCB - $698.6M) - At the Annual Meeting, all nominated directors were elected to serve until 2028, with varying levels of votes withheld. The advisory vote on the compensation of named executive officers for 2024 did not receive majority approval, with more votes against than for. Stockholders ratified the appointment of Crowe LLP as the independent auditor for 2025 and approved an amendment to the 2022 Equity Incentive Plan.

FiscalNote Holdings, Inc. (NOTE - $101.2M) - At FiscalNote Holdings, Inc.’s 2025 annual meeting, stockholders elected all three Class III director nominees to the Board for three-year terms ending in 2028. The nominees—Manoj Jain, Anna Sedgley, and Brandon Sweeney—received strong majority support despite some withheld votes and broker non-votes. Additionally, stockholders ratified the appointment of RSM US LLP as the independent registered public accounting firm for the 2025 fiscal year with overwhelming approval and no broker non-votes.

NUSCALE POWER Corp (SMR - $4.7B) - At the 2025 Annual Meeting, NUSCALE POWER Corp shareholders approved the election of all nominated directors with strong majority votes. The proposals to approve executive compensation, amend the Certificate of Incorporation, and ratify Ernst & Young, LLP as the independent auditor were also approved by significant margins. There were no indications of non-compliance or controversy related to these voting outcomes.

Mercer International Inc. (MERC - $238.1M) - At Mercer International Inc.’s 2025 Annual Meeting, all ten board director nominees were elected with overwhelming shareholder support. The shareholders also approved, on a non-binding advisory basis, the Company’s executive compensation and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025. Additionally, an amendment to the 2022 Stock Incentive Plan was approved, despite notable opposition with over 1.2 million votes against.

Bandwidth Inc. (BAND - $431.9M) - At the 2025 Annual Meeting, Bandwidth Inc. stockholders elected Class II directors John C. Murdock and Douglas A. Suriano to serve until 2028. The stockholders approved the Company’s Third Amended and Restated 2017 Incentive Award Plan and ratified Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2025. Additionally, the stockholders gave advisory approval to the compensation of the Company’s named executive officers.

American Strategic Investment Co. (NYC - $25.6M) - At the 2025 Annual Meeting, American Strategic Investment Co. stockholders re-elected Elizabeth K. Tuppeny as a Class II director and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025. Additionally, stockholders adopted a non-binding advisory resolution approving the compensation of the Company’s named executive officers. No other proposals were submitted or voted upon, and the voting turnout represented approximately 77.43% of shares entitled to vote.

FTAI Infrastructure Inc. (FIP - $712.7M) - At the 2025 Annual Meeting, shareholders elected two Class III directors, Joseph P. Adams, Jr. and Judith A. Hannaway, with Adams receiving significantly more votes for than Hannaway, who had a substantial number of votes withheld. Shareholders also ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2025 with an overwhelming majority voting for. Notably, there were significant broker non-votes on the director elections due to brokers lacking discretionary voting authority, which may affect future governance dynamics.

Elme Communities (ELME - $1.4B) - At Elme Communities' annual meeting on May 29, 2025, shareholders elected nine trustees to the Board, including Jennifer S. Banner, Benjamin S. Butcher, and Susan Carras, each to serve until the 2026 annual meeting. Notably, some trustees such as Paul T. McDermott and Anthony L. Winns received higher levels of opposition votes, with Mr. Winns receiving over 3.5 million votes against. Additionally, shareholders approved the named executive officer compensation in a nonbinding advisory vote, despite receiving over 3 million votes against the proposal.

Goldman Sachs BDC, Inc. (GSBD - $1.3B) - At the May 28, 2025 Annual Meeting, Goldman Sachs BDC stockholders elected the Class II director nominees, including Katherine P. Uniacke, Jaime Ardila, and Richard A. Mark, each receiving a majority of votes cast despite notable opposition and abstentions. Stockholders also ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. There were no indications of non-compliance, litigation, or other negative issues raised in connection with these votes.

Netgear Inc. (NTGR - $877.0M) - At the 2025 Annual Meeting, NETGEAR’s stockholders elected seven directors with all nominees receiving strong majority support, though some faced notable opposition. The stockholders ratified PricewaterhouseCoopers, LLP as the independent auditor and approved an amendment to increase shares under the Employee Stock Purchase Plan by 1.5 million shares. However, the non-binding advisory vote on executive compensation and the 2025 Equity Incentive Plan narrowly passed with significant dissent, indicating potential shareholder concerns about management pay and equity dilution.

Industrial Logistics Properties Trust (ILPT - $218.3M) - At the 2025 Annual Meeting, Industrial Logistics Properties Trust shareholders elected seven Trustees to the Board, with several nominees receiving significant withhold votes, notably Lisa Harris Jones and Adam Portnoy. The non-binding advisory vote on executive compensation passed with strong support, receiving over 34.9 million votes for and only 1.7 million votes against. Shareholders also ratified the appointment of Deloitte & Touche LLP as the independent auditors for the 2025 fiscal year with overwhelming approval.

Pixelworks Inc. (PXLW - $29.5M) - At Pixelworks Inc.’s 2025 Annual Meeting, all nominated directors were elected to the board with strong shareholder support. Shareholders approved a reverse stock split amendment allowing the Board to consolidate shares at a ratio between 1-for-5 and 1-for-12, as well as an increase of 2.5 million shares to the 2006 Stock Incentive Plan. Additionally, the advisory vote on executive compensation was approved, with shareholders opting for an annual frequency of future advisory votes, and the appointment of Grant Thornton LLP as the independent auditor was ratified.

Lafayette Square USA, Inc. - At the May 28, 2025 Annual Meeting, Lafayette Square USA, Inc. stockholders elected Jacqueline Bradley as Class III director with 12,417,294 votes for and zero votes against. The stockholders also ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, with 12,414,057 votes for and zero votes against. There were no abstentions or broker non-votes impacting the outcomes, indicating strong shareholder support for both proposals.

SITIME Corp (SITM - $4.7B) - At the May 30, 2025 Annual Meeting, SiTime Corporation’s stockholders approved the election of three Class II directors to serve until 2028. The stockholders also approved, on an advisory basis, the compensation of the Company’s named executive officers. Additionally, stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2025.

Passage BIO, Inc. (PASG - $22.3M) - At the 2025 Annual Meeting, Passage Bio elected two Class II directors, Maxine Gowen, Ph.D., and Dolan Sondhi, Ph.D., each for a three-year term ending in 2028. The stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for fiscal year 2025. Additionally, shareholders approved giving the Board discretionary authority to implement a reverse stock split of common stock at a ratio between 1-for-5 and 1-for-50 by the end of 2025.

Sirius Xm Holdings Inc. (SIRI - $7.5B) - At the 2025 Annual Meeting, Sirius XM Holdings Inc. stockholders elected Eddy W. Hartenstein, Kristina M. Salen, and Jennifer C. Witz as Class I directors. Stockholders approved, in a non-binding advisory vote, that the Say-on-Pay vote on executive compensation should occur every year, with the Company planning to file an amendment reflecting this decision. Additionally, stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accountants for 2025.

Resolute Holdings Management, Inc. (RHLD - $294.6M) - At the 2025 Annual Meeting, Resolute Holdings Management, Inc. shareholders elected three Class I directors—John D. Cote, Roger Fradin, and Jane J. Thompson—to serve until 2028 or until earlier resignation or removal. The shareholders also ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. There were no indications of non-compliance or contested matters, and quorum was established with 8,085,741 shares represented.

Sealed Air Corp De (SEE - $4.8B) - At Sealed Air Corporation’s 2025 Annual Meeting, all director nominees were elected to serve until 2026, with strong majority votes in favor. Stockholders ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2025. The advisory vote on executive compensation was approved despite a significant minority opposing, indicating some shareholder concern over pay practices.

SoFi Technologies, Inc. (SOFI - $14.8B) - At SoFi Technologies' 2025 annual meeting, all ten director nominees were elected to serve until 2026, with no reported resignations or removals. Stockholders approved, on a non-binding advisory basis, the Company's executive compensation despite a significant minority voting against. The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2025 was ratified by a large majority, indicating continued auditor engagement.

Great Elm Capital Corp. (GECC - $123.4M) - At the 2025 annual meeting, Great Elm Capital Corp. shareholders elected Chad Perry as director with 7,225,709 votes for and 678,522 withheld, alongside 2,067,510 broker non-votes. The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2025 was ratified with 9,686,144 votes for and 278,967 votes against. There were no indications of non-compliance, litigation, or other negative matters raised in the voting results.

Neumora Therapeutics, Inc. (NMRA - $113.1M) - At Neumora Therapeutics’ Annual Meeting on May 28, 2025, stockholders approved the election of two Class II directors, Alaa Halawa and Maykin Ho, Ph.D., to serve until 2028. The stockholders also ratified Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2025 and approved the repricing of certain outstanding stock options under the 2020 and 2023 Incentive Plans. Additionally, stockholders approved amendments to the Certificate of Incorporation authorizing a reverse stock split of common stock at a ratio between 1-for-5 and 1-for-30, to be determined by the Board.

TPG Twin Brook Capital Income Fund - At the 2025 Annual Meeting, TPG Twin Brook Capital Income Fund’s shareholders elected James E. Bowers as Class III Trustee for a three-year term ending in 2028. Shareholders also ratified Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. There were no indications of non-compliance or litigation related to these matters.

89bio, Inc. (ETNB - $1.3B) - At the 89bio, Inc. 2025 Annual Meeting, all director nominees were elected, including Martin Babler, Derek DiRocco, Ph.D., and Lota Zoth, C.P.A. The proposal to ratify KPMG LLP as the independent auditor was approved overwhelmingly with minimal opposition. Additionally, the advisory vote on executive compensation received strong support, indicating shareholder endorsement of the company's pay practices.

A K A Brands Holding Corp (AKA - $137.3M) - At the May 27, 2025 annual meeting, AKA Brands Holding Corp shareholders elected Christopher Dean, Ilene Eskenazi, and Matthew Hamilton to the board of directors for terms ending in 2028. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2025 was ratified with overwhelming support. There were no indications of non-compliance or litigation issues related to these governance matters.

Perella Weinberg Partners (PWP - $1.1B) - At the 2025 Annual Meeting, Perella Weinberg Partners' stockholders elected three Class I directors to serve until 2028, with Andrew Bednar, Kristin W. Mugford, and Joseph R. Perella receiving majority support. The stockholders also ratified Ernst & Young, LLP as the independent registered public accounting firm for fiscal year 2025. Additionally, the stockholders approved the executive compensation package and set the frequency of future advisory votes on compensation to every three years by advisory vote.

Mirum Pharmaceuticals, Inc. (MIRM - $2.2B) - At Mirum Pharmaceuticals' 2025 Annual Meeting, stockholders elected three Class III directors to serve until 2028, with Laura Brege receiving significant votes withheld, indicating potential shareholder concerns. The selection of Ernst & Young LLP as the independent registered public accounting firm for 2025 was overwhelmingly ratified by stockholders. Additionally, the advisory vote on executive compensation was approved, though over 1.4 million votes were cast against, signaling some shareholder dissatisfaction.

agilon health, inc. (AGL - $923.1M) - At the May 28, 2025 annual meeting, agilon health, inc. elected Silvana Battaglia and Sharad Mansukani, M.D. to its Board of Directors as Class I directors through 2028. Stockholders ratified Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2025. The advisory, non-binding vote on executive compensation was approved, though with significant opposition totaling over 83 million votes against.

GRAIL, Inc. (GRAL - $1.5B) - At the May 29, 2025 Annual Meeting, GRAIL, Inc. stockholders elected William Chase as Class I Director with 19,046,188 votes for and 1,234,461 votes withheld. Stockholders also ratified Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2025 with overwhelming support, receiving 29,086,225 votes for and only 66,878 votes against. No negative or contentious issues were reported in the voting results.

Atlas Lithium Corp (ATLX - $72.2M) - At Atlas Lithium Corp’s 2025 Annual Meeting, all nominees were elected to the Board of Directors, securing their positions until the next annual meeting. The stockholders ratified the appointment of Pipara & Co. LLP as the independent registered public accounting firm for fiscal year 2025. Additionally, proposals to approve equity grants to non-employee directors and to amend the 2023 Stock Incentive Plan were both approved by the shareholders.

Delistings ⚠️

Adial Pharmaceuticals Inc. (ADIL - $5.3M) - Adial Pharmaceuticals received a notice of non-compliance from Nasdaq due to its stockholders’ equity of $2.13 million falling below the $2.5 million minimum requirement under Nasdaq Listing Rule 5550(b)(1). The Company must submit a Compliance Plan by July 7, 2025, to regain compliance and may receive up to a 180-day extension if the plan is accepted, but there is no assurance the plan will be approved. Failure to comply or have the plan accepted could lead to a hearing before Nasdaq’s Hearing Panel and potential delisting if compliance is not restored.

Iveda Solutions, Inc. (IVDA - $5.8M) - Iveda Solutions, Inc. received a notice of non-compliance from Nasdaq for failing to maintain the minimum required stockholders’ equity of $2,500,000, reporting only $1,700,887 as of March 31, 2025. The Company has 45 days to submit a plan to regain compliance and, if accepted, up to 180 days to meet the requirement, but there is no assurance the plan will be accepted or that compliance will be achieved. Failure to comply or an unsuccessful appeal could lead to delisting, posing a significant risk to the Company’s continued Nasdaq listing.

MetaVia Inc. (MTVA - $15.1M) - MetaVia Inc. received a Notice of Non-Compliance from Nasdaq due to its common stock closing below $1.00 per share for 30 consecutive business days, violating the minimum bid price requirement. The Company has 180 days, until November 25, 2025, to regain compliance by achieving a closing bid price at or above $1.00 for 10 consecutive business days, or it risks delisting from The Nasdaq Capital Market. If compliance is not met, MetaVia may seek an additional 180-day extension by meeting other listing standards and potentially executing a reverse stock split, but failure to cure the deficiency could lead to delisting and a subsequent appeal process.

Vsee Health Inc. (VSEE - $20.2M) - VSee Health, Inc. received a notice of non-compliance from Nasdaq for failing to timely file its Form 10-Q for the quarter ended March 31, 2025, violating Nasdaq Listing Rule 5250(c)(1). The Company has 60 days to submit a plan to regain compliance, with a potential extension of up to 180 days if Nasdaq accepts the plan, but there is no assurance the plan will be submitted, accepted, or that the Company will meet continued listing requirements. Failure to resolve this issue could lead to delisting of VSee’s common stock and public warrants from Nasdaq, posing a significant risk to shareholders.

LogicMark, Inc. (LGMK - $6.6M) - LogicMark, Inc. received a notice of delisting from Nasdaq due to its failure to meet the minimum bid price requirement of $1.00 per share, with trading on Nasdaq to be suspended effective June 2, 2025. The Company does not intend to appeal this determination and plans to have its common stock quoted on the OTC Markets under the symbol "LGMK" following delisting. There were no findings of non-compliance related to its February 2025 offering, but the delisting poses significant liquidity and market visibility risks for shareholders.

ReShape Lifesciences Inc. (RSLS - $3.5M) - ReShape Lifesciences Inc. received a notice of delisting from Nasdaq due to failure to meet the minimum $2,500,000 stockholders’ equity requirement and did not comply with the extension deadline of May 27, 2025. Unless the Company successfully appeals by June 4, 2025, trading will be suspended and the stock will be removed from Nasdaq effective June 6, 2025. The Company intends to appeal, but there is no assurance the appeal will be granted or that it can maintain compliance with Nasdaq listing rules.

Imunon, Inc. (IMNN - $39.8M) - Imunon, Inc. received a delisting determination from Nasdaq due to failure to meet the minimum bid price and minimum stockholders’ equity requirements, with trading suspension set for June 6, 2025 unless a hearing is requested. The Company plans to request a hearing to appeal the delisting and seek a suspension of trading suspension pending the outcome, which could extend listing for 30-45 days. Imunon intends to propose a plan to regain compliance, potentially including a reverse stock split, but there is no assurance the Company will successfully regain compliance or that the appeal will be granted.

ZyVersa Therapeutics, Inc. (ZVSA - $2.8M) - ZyVersa Therapeutics, Inc. received a Minimum Bid Price Deficiency Letter from Nasdaq notifying the Company that its common stock has been trading below $1.00 for 30 consecutive business days, resulting in non-compliance with Listing Rule 5550(a)(2). Due to recent reverse stock splits totaling a 1-for-350 cumulative ratio, ZyVersa is not eligible for the customary 180-day Cure Period and faces imminent delisting on June 5, 2025 unless it successfully appeals. The Company intends to request a hearing to stay the delisting, but there is no assurance it will regain compliance or maintain its Nasdaq listing.

Citius Pharmaceuticals, Inc. (CTXR - $7.3M) - Citius Pharmaceuticals, Inc. received a notice of non-compliance from Nasdaq for failing to maintain a minimum bid price of $1.00 per share for 33 consecutive business days, and is not eligible for a compliance period due to a recent reverse stock split. The Company intends to appeal the delisting determination by June 5, 2025, which will temporarily stay the delisting pending a decision by the Nasdaq Hearings Panel. There is no assurance the Panel will grant relief or that the Company will regain compliance, posing a significant risk of delisting from The Nasdaq Capital Market.

Healthcare Triangle, Inc. (HCTI - $2.5M) - Healthcare Triangle, Inc. received a delisting notice from Nasdaq due to its securities trading below $1 per share for 30 consecutive business days and further triggered a Staff Delisting Determination after the stock closed at $0.10 or less for ten consecutive trading days. Nasdaq also cited a Public Interest Concern related to substantial shareholder dilution from a recent private placement involving Series A and B Warrants. The Company is contesting these findings with the Nasdaq Hearings Panel but there is no assurance it will regain compliance or avoid delisting from the Nasdaq Capital Market.

La Rosa Holdings Corp. (LRHC - $5.6M) - La Rosa Holdings Corp. is non-compliant with Nasdaq Listing Rule 5550(b)(1) due to negative stockholders’ equity of $(83.4) million as of March 31, 2025, falling well below the $2.5 million minimum requirement. The Company has until July 14, 2025, to submit a plan to regain compliance, with potential relief extending to November 26, 2025, but there is no assurance the plan will be accepted or that compliance will be restored. Failure to regain compliance could lead to delisting, although the Company may appeal any such decision to a Nasdaq Hearings Panel.

bioAffinity Technologies, Inc. (BIAF - $7.4M) - bioAffinity Technologies, Inc. received a notice of non-compliance from Nasdaq for failing to meet the minimum stockholders’ equity requirement of $2.5 million, reporting only $1.44 million as of March 31, 2025. The Company must submit a Compliance Plan by July 11, 2025, to regain compliance and potentially receive up to 180 days to cure the deficiency, but there is no assurance the plan will be accepted. Failure to comply or have the plan accepted could lead to a hearing before Nasdaq’s Hearing Panel and possible delisting, compounding an existing deficiency related to the minimum bid price requirement.